Thyrocare Technologies Limited (BOM:539871)
India · Delayed Price · Currency is INR 510.60
-5.15 (-1.00%)
At close: Jul 13, 2026
Thyrocare Technologies Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Thyrocare Technologies stock has a consensus rating of "Strong Buy" and an average price target of ₹603.00. The average 1-year stock price forecast is 18.10% higher than the current stock price, while the lowest is ₹550.00 (+7.72%) and the highest is ₹650.00 (+27.30%).
Price Target: ₹603.00 (+18.10%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Thyrocare Technologies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Oct '25 | Jan '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 4 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 4 | 5 |
Financial Forecast
Revenue This Year
9.78B
from 8.29B
Increased by 17.98%
Revenue Next Year
11.42B
from 9.78B
Increased by 16.77%
EPS This Year
12.18
from 10.54
Increased by 15.56%
EPS Next Year
14.88
from 12.18
Increased by 22.17%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 10.0B | ||
| Avg | 9.8B | ||
| Low | 9.7B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 20.3% | ||
| Avg | 18.0% | ||
| Low | 17.1% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 12.50 | ||
| Avg | 12.18 | ||
| Low | 11.90 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 18.6% | ||
| Avg | 15.6% | ||
| Low | 12.9% |